YOLFTbeta
ilShinbiobase Co. Ltd

ilShinbiobase Co. Ltd

068330 · KQ

978.00KRW-1.00 (-0.10%)

Price History

Full chart

Market Stats

Previous Close979.00
Open988.00
Day Range977.00 – 993.00
52-Week Range851.00 – 2,041.97
Volume33.59K
Market Cap43.68B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.33%
Beta1.79
50-Day Avg1,015.64
200-Day Avg1,306.16

About

ilShinbiobase Co. Ltd. manufactures and sells industrial refrigeration equipment in Korea. It offers laboratory, pilot, and plant scale, as well as auto loading/unloading systems; deep and quick freezers; and blood bank and pharmaceutical refrigerators. The company also provides ice makers and shakers. It also exports its products to approximately 100 countries. The company was formerly known as iLShinLab Co., Ltd. and changed its name to ilShinbiobase Co. Ltd. in 2009. The company was founded in 1988 and is headquartered in Dongducheon, South Korea.

Company Details

  • CEOMr. Seong-Dae Hong
  • Employees0
  • Headquarters84, Samyuksa-ro 548beon-gil, Dongducheon-Si, South Korea, Korea
  • Websitehttps://www.1sbb.com

Leadership

  • Mr. Seong-Dae HongChief Exec. Officer and Representative Director · b. 1959
  • Bang Taek LimDirector of Domestic Sales
  • Jae-Yong KimChief of R&D Center and Director · b. 1968

Financials

Income Statement

Currency: KRW2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue9.72B12.36B12.90B13.36B12.84B15.38B19.64B21.04B24.38B20.43B16.44B10.82B14.53B
Growth (%)-+27.10%+4.34%+3.58%-3.89%+19.83%+27.64%+7.13%+15.89%-16.18%-19.56%-34.19%+34.32%
Cost of Revenue5.06B6.43B6.98B7.04B6.74B8.45B8.76B10.66B11.27B9.92B7.01B4.54B6.81B
Gross Profit-5.42B5.92B6.32B6.09B6.94B10.87B10.37B13.11B10.51B9.43B6.28B7.72B
Gross Margin-43.85%45.87%47.29%47.48%45.10%55.37%49.30%53.77%51.44%57.36%58.03%53.15%
Operating Expense-3.35B3.41B3.31B3.75B3.90B5.66B5.35B5.33B5.35B3.21B4.02B3.16B
Operating Income1.12B2.07B2.50B3.01B2.34B3.04B5.21B5.02B7.78B5.16B6.21B2.26B4.56B
Operating Margin11.51%16.79%19.40%22.53%18.24%19.74%26.56%23.88%31.90%25.26%37.81%20.91%31.40%
EBITDA---------5.17B8.22B2.70B5.00B
EBITDA Margin---------25.28%49.98%24.98%34.39%
Net Income997.15M1.87B2.56B2.69B2.10B3.16B4.65B4.48B6.24B3.82B6.23B3.81B4.79B
Net Income Margin10.25%15.09%19.82%20.15%16.40%20.55%23.70%21.29%25.61%18.67%37.92%35.24%32.99%
R&D492.67M599.33M585.51M528.81M454.82M471.67M---608.56M636.99M627.12M745.58M
R&D as % of Total Revenue5.07%4.85%4.54%3.96%3.54%3.07%---2.98%3.88%5.80%5.13%
Interest Expense00000000084.00K2.00K--
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%--

Balance Sheet

Currency: KRW2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets26.83B28.22B29.57B37.66B38.49B39.53B45.63B49.55B56.83B58.45B60.62B63.94B68.58B
Total Liabilities4.54B3.93B5.30B4.68B3.27B3.81B5.47B5.17B6.36B4.63B3.55B3.49B3.79B
Total Equity22.21B24.21B24.30B32.98B35.22B35.72B40.16B44.38B50.47B53.82B57.06B60.45B64.80B
Cash1.34B3.03B2.01B4.02B5.27B5.64B6.09B9.05B11.37B5.71B3.15B1.73B1.98B

Cash Flow

Currency: KRW2008-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow--3.33B270.22M3.01B2.11B4.88B5.55B4.50B6.74B2.65B5.92B4.12B5.27B
Investing Cash Flow-1.18B-138.07M133.70M-7.44B-682.33M-1.92B-4.89B-1.16B-4.11B----
Financing Cash Flow---1.50B-1.43B6.40B-2.64B-2.64B-214.33M-300.06M-308.53M----
Capital Expenditure0176.90M101.50M99.39M271.94M407.59M385.81M245.41M892.64M139.12M522.59M262.17M53.53M20.64M
Free Cash Flow----------2.12B5.66B4.07B5.25B
Dividends Paid--214.24M214.24M214.33M214.33M214.33M214.33M300.06M300.06M300.06M300.06M291.74M291.74M
FCF to OCF----------80.25%95.57%98.70%99.61%
Dividend Paid to FCF----------14.13%5.30%7.17%5.56%

Earnings

Report DateMar 31, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------------------------------------------------------------
EPS Actual15.5815.935.7116.2915.9412.0814.774.13-3.724.3310.2914.044.828.5611.4011.43-3.6327.06-5.827.0914.9723.6817.897.7010.8911.6011.109.5328.433.9022.125.1217.0517.6616.8714.8522.0010.5134.2155.708.1132.1427.2221.1420.2828.6944.2319.2244.5227.8516.0628.4516.6526.6660.33-5.9464.4313.7119.267.1445.8315.8917.8146.1535.1523.4039.57
Surprise-------------------------------------------------------------------
Timing-------------------------------------------------------------------

Key Statistics & Ratios

Market Cap43.68B
Enterprise Value-5.75B
Trailing P/E0.00
Forward P/E0.00
Price / Sales2.65
Price / Book0.62
Revenue (TTM)18.34B
Gross Profit (TTM)10.42B
EBITDA4.25B
Profit Margin21.58%
Operating Margin20.06%
Return on Equity8.06%
Return on Assets4.83%
Shares Outstanding41.70M
Shares Float29.31M
Beta1.79
Dividend Yield0.33%
Dividend Rate0.00
Payout Ratio6.93%

Dividends

20251×
10.00Dec 29, 2025
20241×
7.00Dec 27, 2024
20231×
7.00Dec 27, 2023
20221×
7.00Dec 28, 2022
20211×
7.00Dec 29, 2021
20201×
7.00Dec 29, 2020
20191×
7.00Dec 27, 2019
20181×
5.00Dec 27, 2018
20141×
5.00Dec 29, 2014
20101×
4.96Dec 29, 2010
20091×
4.96Dec 29, 2009
20081×
2.48Dec 29, 2008
20071×
2.48Dec 27, 2007

Stock Splits

  • Feb 11, 20145:1
  • Dec 27, 201211:10
  • Dec 28, 201111:10
  • Oct 2, 20082:1